Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT01300871
What this trial is testing

Alopecia Secondary to Endocrine Therapy in Postmenopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
University Health Network, Toronto 100
Early research (Phase 1)Study completedNCT01837095
What this trial is testing

Dose Escalation of POL6326 in Combination With Eribulin in Patients With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Polyphor Ltd. 54
Early research (Phase 1)Study completedNCT00003107
What this trial is testing

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more
Indiana University
Early research (Phase 1)Study completedNCT05567601
What this trial is testing

Doxil/Caelyx BE Study

Who this might be right for
Ovarian CancerAIDS-related Kaposi SarcomaMultiple Myeloma+1 more
Baxter Healthcare Corporation 36
Testing effectiveness (Phase 2)Study completedNCT05960201
What this trial is testing

Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in Invasive Lobular Carcinoma

Who this might be right for
Carcinoma, Lobular
Asan Medical Center 23
Early research (Phase 1)WithdrawnNCT02483871
What this trial is testing

Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine Therapy

Who this might be right for
Breast Cancer
Duke University
Large-scale testing (Phase 3)UnknownNCT02344472
What this trial is testing

Detect V / CHEVENDO (Chemo vs. Endo)

Who this might be right for
Metastatic Breast Cancer
Prof. Wolfgang Janni 271
Post-approval studies (Phase 4)Study completedNCT02447328
What this trial is testing

A Single Arm, Tolerability and Safety Phase IV Study of Fulvestrant(Faslodex® ) as 2nd Line and Later Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Locally Advanced orMetastatic Breast Cancer
AstraZeneca 83
Large-scale testing (Phase 3)Active Not RecruitingNCT01646034
What this trial is testing

High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer

Who this might be right for
Breast Cancer
The Netherlands Cancer Institute 74
Early research (Phase 1)Study completedNCT00573495
What this trial is testing

Multipeptide Vaccine for Advanced Breast Cancer

Who this might be right for
Breast NeoplasmBreast CancerCancer of the Breast+1 more
University of Pennsylvania 11
Testing effectiveness (Phase 2)Study completedNCT01019577
What this trial is testing

Clinical Study of Ixabepilone (BMS-247550) by Every-3-week Dosing Regimen in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and Who Are Taxane Resistant

Who this might be right for
Metastatic Breast Cancer
R-Pharm 54
Testing effectiveness (Phase 2)Study completedNCT00077857
What this trial is testing

Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 470
Early research (Phase 1)Study completedNCT01861509
What this trial is testing

BP-C1 in Metastatic Breast Cancer Patients

Who this might be right for
Metastatic Breast CancerStage IV Breast Cancer
Meabco A/S 10
Testing effectiveness (Phase 2)Looking for participantsNCT06092892
What this trial is testing

IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases

Who this might be right for
Breast CancerAxillary Nodal DiseaseFemale Breast Cancer+3 more
Alice Chung 45
Testing effectiveness (Phase 2)Ended earlyNCT00281528
What this trial is testing

Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasm Metastasis
Celgene 208
Early research (Phase 1)Study completedNCT00020267
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Lung CancerAdult Soft Tissue SarcomaColorectal Cancer+8 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT04947189
What this trial is testing

Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
St Vincent's Hospital, Sydney 65
Testing effectiveness (Phase 2)Active Not RecruitingNCT04225117
What this trial is testing

Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)

Who this might be right for
Locally Advanced or Metastatic Malignant Solid Tumors
Astellas Pharma Global Development, Inc. 329
Large-scale testing (Phase 3)Ended earlyNCT03199885
What this trial is testing

Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer

Who this might be right for
Metastatic Breast AdenocarcinomaMetastatic HER2-Positive Breast CarcinomaRecurrent Breast Adenocarcinoma+5 more
National Cancer Institute (NCI) 190
Testing effectiveness (Phase 2)Study completedNCT00471276
What this trial is testing

Efficacy And Safety Of Sunitinib In Women With Advanced Breast Cancer

Who this might be right for
Breast Neoplasms
Pfizer 83
Next Page